Skip to main content
Erschienen in: Irish Journal of Medical Science (1971 -) 4/2020

18.05.2020 | COVID-19 | Review Article Zur Zeit gratis

COVID-19 in adults: test menu for hospital blood science laboratories

verfasst von: Paula M. O’Shea, Graham Robert Lee, Tomás P. Griffin, Vincent Tormey, Amjad Hayat, Seán J. Costelloe, Damian Gerard Griffin, Saradha Srinivasan, Maurice O’Kane, Conor M. Burke, John Faul, Christopher J. Thompson, Gerard Curley, William P. Tormey

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Coronavirus disease 2019 (COVID-19), is a respiratory illness caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The Clinical Blood Sciences Laboratory (CBSL) plays a key role in supporting the monitoring and management of patients with COVID-19 disease.

Objective

To provide a comprehensive CBSL testing protocol to support the medical management of SARS-CoV-2 infection.

Methods

Description of the biochemical, haematological and immunological tests that have a role in the assessment and monitoring of patients with COVID-19 infection.

Results

We provide a test menu for clinical laboratories to ensure the effective monitoring, management and prognostication of COVID-19 patients in hospital.

Conclusion

Given the rapidity with which patients with COVID-19 disease can deteriorate, we recommend regular testing with vigilance paid to the rate and trajectory of change in each of these parameters.
Literatur
3.
Zurück zum Zitat Mehta P, McAuley DF, Brown M et al (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395:1033–1034CrossRef Mehta P, McAuley DF, Brown M et al (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395:1033–1034CrossRef
5.
Zurück zum Zitat Lippi G, Plebani M (2020) Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chim Acta 505:190–191CrossRef Lippi G, Plebani M (2020) Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chim Acta 505:190–191CrossRef
8.
Zurück zum Zitat Guan WJ, Ni ZY, Hu Y, China Medical Treatment Expert Group for Covid-19 et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708–1720CrossRef Guan WJ, Ni ZY, Hu Y, China Medical Treatment Expert Group for Covid-19 et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708–1720CrossRef
9.
Zurück zum Zitat Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506CrossRef Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506CrossRef
11.
Zurück zum Zitat Hamming I, Timens W, Bulthuis ML et al (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203:631–637CrossRef Hamming I, Timens W, Bulthuis ML et al (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203:631–637CrossRef
12.
Zurück zum Zitat Vaduganathan M, Vardeny O, Michel T et al (2020) Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med 382:1653–1659CrossRef Vaduganathan M, Vardeny O, Michel T et al (2020) Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med 382:1653–1659CrossRef
13.
Zurück zum Zitat Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054–1062CrossRef Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054–1062CrossRef
14.
Zurück zum Zitat Cheng Y, Luo R, Wang K et al (2020) Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97:829–838CrossRef Cheng Y, Luo R, Wang K et al (2020) Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97:829–838CrossRef
15.
Zurück zum Zitat Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRef Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRef
16.
Zurück zum Zitat Simmons J, Pittet JF (2015) The coagulopathy of acute sepsis. Curr Opin Anaesthesiol 28:227–236CrossRef Simmons J, Pittet JF (2015) The coagulopathy of acute sepsis. Curr Opin Anaesthesiol 28:227–236CrossRef
18.
Zurück zum Zitat Kwong JC, Schwartz KL, Campitelli MA et al (2018) Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med 378:345–353CrossRef Kwong JC, Schwartz KL, Campitelli MA et al (2018) Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med 378:345–353CrossRef
19.
Zurück zum Zitat Nguyen JL, Yang W, Ito K et al (2016) Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiol 1:274–281CrossRef Nguyen JL, Yang W, Ito K et al (2016) Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiol 1:274–281CrossRef
20.
Zurück zum Zitat Smeeth L, Thomas SL, Hall AJ et al (2004) Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351:2611–2618CrossRef Smeeth L, Thomas SL, Hall AJ et al (2004) Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 351:2611–2618CrossRef
27.
Zurück zum Zitat Vankadari N, Wilce JA (2020) Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect 9:601–604CrossRef Vankadari N, Wilce JA (2020) Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect 9:601–604CrossRef
28.
Zurück zum Zitat Komolmit P, Charoensuk K, Thanapirom K et al (2017) Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: a randomised double-blinded, placebo-control trial. PLoS One 12:e0174608CrossRef Komolmit P, Charoensuk K, Thanapirom K et al (2017) Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: a randomised double-blinded, placebo-control trial. PLoS One 12:e0174608CrossRef
29.
Zurück zum Zitat Sadeghi K, Wessner B, Laggner U et al (2006) Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 36:361–370CrossRef Sadeghi K, Wessner B, Laggner U et al (2006) Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 36:361–370CrossRef
30.
Zurück zum Zitat McCartney DM, Byrne DG (2020) Optimisation of vitamin D status for enhanced immuno-protection against Covid-19. Ir Med J 113:58PubMed McCartney DM, Byrne DG (2020) Optimisation of vitamin D status for enhanced immuno-protection against Covid-19. Ir Med J 113:58PubMed
Metadaten
Titel
COVID-19 in adults: test menu for hospital blood science laboratories
verfasst von
Paula M. O’Shea
Graham Robert Lee
Tomás P. Griffin
Vincent Tormey
Amjad Hayat
Seán J. Costelloe
Damian Gerard Griffin
Saradha Srinivasan
Maurice O’Kane
Conor M. Burke
John Faul
Christopher J. Thompson
Gerard Curley
William P. Tormey
Publikationsdatum
18.05.2020
Verlag
Springer London
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 4/2020
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-020-02252-0

Weitere Artikel der Ausgabe 4/2020

Irish Journal of Medical Science (1971 -) 4/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.